RxDoctor Payments Data

Cindy Pratt, MD

Nurse Practitioner · Douglasville, GANPI 1114990595

Payments from drug & device makers

$5,228in general payments, 2019–2025

Across 321 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Amgen$499
  • Lilly USA, LLC$346
  • AbbVie$329
  • AstraZeneca$285
  • Novartis$270
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$5,228100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,228 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.

See all nurse practitioner providers in Georgia

Medicare billing

Part B allowed, 2024
$30,981
Medicare patients
217
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin65$84,280
OzempicSemaglutide55$67,820
FarxigaDapagliflozin Propanediol42$53,994
EliquisApixaban48$42,489
TrulicityDulaglutide20$31,360
JanuviaSitagliptin Phosphate24$31,042
MounjaroTirzepatide23$30,374
Soliqua 100-33Insulin Glargine/Lixisenatide28$21,247
RybelsusSemaglutide20$20,283
XareltoRivaroxaban23$18,059
TradjentaLinagliptin17$16,555
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,452
Xigduo XrDapaglifloz Propaned/Metformin15$13,833
Rosuvastatin Calcium378$4,595
Levothyroxine Sodium352$3,538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$245$100,83582 claims
Novo NordiskOzempic, Rybelsus$1,018$88,10475 claims
Lilly USA, LLCTrulicity, Mounjaro$346$61,73443 claims
AstraZenecaFarxiga$285$53,99442 claims
PfizerEliquis$176$42,48948 claims
MerckJanuvia$146$31,04224 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$215$21,24728 claims
GSKTrelegy Ellipta$88$14,45219 claims
AbbVieSynthroid$329$2,39437 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.

Other nurse practitioner in Douglasville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →